Trying to unravel an unresolved issue in regenerative medicine: Gene expression profiling of MSCs;Genexpressionsmuster mesenchymaler Stammzellen: Ein ungelöster Aspekt in der regenerativen Medizin

Laryngo- Rhino- Otologie

Volumn 92, Issue 7, 2013, Pages 462-469

  Jakob, M ^a   Bruderek, K ^b   Bootz, F ^a   Lang, S ^b   Brandau, S ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

differentiation; gene expression profiling; inflammation; mesenchymal stem cells; salivary glands

Indexed keywords

ENDOTOXIN; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STRESS; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MESENCHYMAL STEM CELL; PAROTID GLAND; PRIORITY JOURNAL; REGENERATIVE MEDICINE;

ADULT; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGENETIC PHENOMENA; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERONS; INTERLEUKINS; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAROTID GLAND; REGENERATIVE MEDICINE; TISSUE SURVIVAL; TOLL-LIKE RECEPTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879928938     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0033-1337982     Document Type: Article

References (37)

1. Lin T. M., Chang H. W., Wang K. H., Kao A. P., Chang C. C., Wen C. H., Lai C. S., Lin S. D. Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun: 2007; 361 883 889
2. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., Blake J., Schwager C., Eckstein V., Ansorge W., Ho A. D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol: 2005; 33 1402 1416
3. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells: 2007; 25 2739 2749
4. Rotter N., Oder J., Schlenke P., Lindner U., Bohrnsen F., Kramer J., Rohwedel J., Huss R., Brandau S., Wollenberg B., Lang S. Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev: 2008; 17 509 518
5. Jakob M., Hemeda H., Janeschik S., Bootz F., Rotter N., Lang S., Brandau S. Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev: 2010; 19 635 644
6. Bohrnsen F., Rotter N., Lindner U., Meier M., Wollenberg B., Rohwedel J., Kramer J. Human mesenchymal stromal cells from adipose tissue of the neck. Eur Arch Otorhinolaryngol: 2012
7. Friedenstein A. J., Gorskaja J. F., Kulagina N. N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol: 1976; 4 267 274
8. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W., Ringden O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet: 2008; 371 1579 1586
9. Ciccocioppo R., Bernardo M. E., Sgarella A., Maccario R., Avanzini M. A., Ubezio C., Minelli A., Alvisi C., Vanoli A., Calliada F., Dionigi P., Perotti C., Locatelli F., Corazza G. R. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut: 2011; 60 788 798
10. Duijvestein M., Vos A. C., Roelofs H., Wildenberg M. E., Wendrich B. B., Verspaget H. W., Kooy-Winkelaar E. M., Koning F., Zwaginga J. J., Fidder H. H., Verhaar A. P., Fibbe W. E., van den Brink G. R., Hommes D. W. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut: 2010; 59 1662 1669
11. Le Blanc K., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol: 2012; 12 383 396
12. Brandau S., Jakob M., Hemeda H., Bruderek K., Janeschik S., Bootz F., Lang S. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol: 2010; 88 1005 1015
13. Jakob M., Hemeda H., Bruderek K., Gerstner AO H., Bootz F., Lang S., Brandau S. Comparative functional cell biological analysis of mesenchymal stem cells of the head and neck region: Potential impact on wound healing, trauma, and infection. Head Neck: 2012; 10.1002/hed.23196 [doi]
14. Harris H. E., Andersson U., Pisetsky D. S. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol: 2012; 8 195 202
15. Fitzgerald K. A., Rowe D. C., Barnes B. J., Caffrey D. R., Visintin A., Latz E., Monks B., Pitha P. M., Golenbock D. T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med: 2003; 198 1043 1055
16. Hemeda H., Jakob M., Ludwig A. K., Giebel B., Lang S., Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev: 2010; 19 693 706
17. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy: 2006; 8 315 317
18. Lombaert I. M., Brunsting J. F., Wierenga P. K., Faber H., Stokman M. A., Kok T., Visser W. H., Kampinga H. H., de H. G., Coppes R. P. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE: 2008; 3 e2063
19. Connick P., Kolappan M., Crawley C., Webber D. J., Patani R., Michell A. W., Du M. Q., Luan S. L., Altmann D. R., Thompson A. J., Compston A., Scott M. A., Miller D. H., Chandran S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol: 2012; 11 150 156
20. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzon I. M., Nepomnaschy I., Costa H., Canones C., Raiden S., Vermeulen M., Geffner J. R. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE: 2010; 5 e9252
21. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol: 2006; 36 2566 2573
22. Carrero R., Cerrada I., Lledo E., Dopazo J., Garcia-Garcia F., Rubio M. P., Trigueros C., Dorronsoro A., Ruiz-Sauri A., Montero J. A., Sepulveda P. IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev: 2012; 8 905 916 10.1007/s12015-012-9364-9 [doi]
23. Park M. J., Shin J. S., Kim Y. H., Hong S. H., Yang S. H., Shin J. Y., Kim S. Y., Kim B., Kim J. S., Park C. G. Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor alpha (CD25) cleavage by producing matrix metalloproteinases. Stem Cell Rev: 2011; 7 381 393 10.1007/s12015-010- 9203-9 [doi]
24. Voehringer D. Basophil modulation by cytokine instruction. Eur J Immunol: 2012; 42 2544 2550 10.1002/eji.201142318 [doi]
25. Levine S. J., Wenzel S. E. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes. Ann Intern Med: 2010; 152 232 237 152/4/232 [pii] 10.1059/0003-4819-152-4-201002160- 00008 [doi]
26. Keller E. T., Wanagat J., Ershler W. B. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci: 1996; 1 d340 d357
27. Finnerty C. C., Herndon D. N., Przkora R., Pereira C. T., Oliveira H. M., Queiroz D. M., Rocha A. M., Jeschke M. G. Cytokine expression profile over time in severely burned pediatric patients. Shock: 2006; 26 13 19
28. Matsushima K., Oppenheim J. J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine: 1989; 1 2 13
29. Chow A., Lucas D., Hidalgo A., Mendez-Ferrer S., Hashimoto D., Scheiermann C., Battista M., Leboeuf M., Prophete C., van R. N., Tanaka M., Merad M., Frenette P. S. Bone marrow CD169 + macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med: 2011; 208 261 271 jem.20101688 [pii] 10.1084/jem.20101688 [doi]
30. Mosser D. M., Edwards J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol: 2008; 8 958 969 nri2448 [pii] 10.1038/nri2448 [doi]
31. Wakefield L. M., Roberts A. B., Assoian R. K., Fanger B. O., Masui T., Lechner J. F., Harris C. C., Sporn M. B. Structure and function of transforming growth factor-beta. Proc West Pharmacol Soc: 1986; 29 475 477
32. Darnell J. E. Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science: 1994; 264 1415 1421
33. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol: 2004; 5 987 995
34. van den Berk L. C., Jansen B. J., Siebers-Vermeulen K. G., Netea M. G., Latuhihin T., Bergevoet S., Raymakers R. A., Kogler G., Figdor C. C., Adema G. J., Torensma R. Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med: 2009; 13 3415 3426
35. Liotta F., Angeli R., Cosmi L., Fili L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M. L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells: 2008; 26 279 289
36. Romieu-Mourez R., Francois M., Boivin M. N., Bouchentouf M., Spaner D. E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol: 2009; 182 7963 7973
37. Lombardo E., DelaRosa O., Mancheno-Corvo P., Menta R., Ramirez C., Buscher D. Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. Tissue Eng Part A: 2009; 15 1579 1589